• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Drug Discov Ther . Targeting Lymphocyte Kv1.3-channels to Suppress Cytokine Storm in Severe COVID-19: Can It Be a Novel Therapeutic Strategy?

tetano

Editor, Senior Moderator
Drug Discov Ther


. 2020 Jun 25.
doi: 10.5582/ddt.2020.03046. Online ahead of print.
Targeting Lymphocyte Kv1.3-channels to Suppress Cytokine Storm in Severe COVID-19: Can It Be a Novel Therapeutic Strategy?


Itsuro Kazama[SUP] 1 [/SUP]



Affiliations

Abstract

In the midst of a pandemic, finding effective treatments for coronavirus disease 2019 (COVID-19) is the urgent issue. In "chronic inflammatory diseases", the overexpression of delayed rectifier K[SUP]+[/SUP]-channels (Kv1.3) in leukocytes is responsible for the overactivation of cellular immunity and the subsequent cytokine storm. In our previous basic studies, drugs including chloroquine and azithromycin strongly suppressed the channel activity and pro-inflammatory cytokine production from lymphocytes. These findings suggest a novel pharmacological mechanism by which chloroquine, with or without azithromycin, is effective for severe cases of COVID-19, in which the overactivation of cellular immunity and the subsequent cytokine storm are responsible for the pathogenesis.

Keywords: COVID-19; Kv1.3-channels; chloroquine; cytokine storm; lymphocyte.
 
Back
Top Bottom